167 related articles for article (PubMed ID: 23612030)
21. Loss of cytokeratin 20 and acquisition of thyroid transcription factor-1 expression in a merkel cell carcinoma metastasis to the brain.
Shalin SC; Cifarelli CP; Suen JY; Gao L
Am J Dermatopathol; 2014 Nov; 36(11):904-6. PubMed ID: 24901475
[TBL] [Abstract][Full Text] [Related]
22. [Merkel cell carcinoma--immunohistochemical study in a group of 11 patients].
Jirásek T; Matej R; Pock L; Knotková I; Mandys V
Cesk Patol; 2009 Jan; 45(1):9-13. PubMed ID: 19402315
[TBL] [Abstract][Full Text] [Related]
23. PAX2 and PAX8: useful markers for metastatic effusions.
Waters L; Crumley S; Truong L; Mody D; Coffey D
Acta Cytol; 2014; 58(1):60-6. PubMed ID: 24334997
[TBL] [Abstract][Full Text] [Related]
24. PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system.
Carney EM; Banerjee P; Ellis CL; Albadine R; Sharma R; Chaux AM; Burger PC; Netto GJ
Am J Surg Pathol; 2011 Feb; 35(2):262-7. PubMed ID: 21263247
[TBL] [Abstract][Full Text] [Related]
25. PAX2 and PAX8 expression in primary and metastatic müllerian epithelial tumors: a comprehensive comparison.
Ozcan A; Liles N; Coffey D; Shen SS; Truong LD
Am J Surg Pathol; 2011 Dec; 35(12):1837-47. PubMed ID: 21989345
[TBL] [Abstract][Full Text] [Related]
26. Analysis of thyroid transcription factor-1 and cytokeratin 20 separates merkel cell carcinoma from small cell carcinoma of lung.
Hanly AJ; Elgart GW; Jorda M; Smith J; Nadji M
J Cutan Pathol; 2000 Mar; 27(3):118-20. PubMed ID: 10728812
[TBL] [Abstract][Full Text] [Related]
27. TTF-1 and PAX5 Are Frequently Expressed in Combined Merkel Cell Carcinoma.
Czapiewski P; Majewska H; Kutzner H; Kazakov D; Renkielska A; Biernat W
Am J Dermatopathol; 2016 Jul; 38(7):513-6. PubMed ID: 27322785
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Ye J; Hameed O; Findeis-Hosey JJ; Fan L; Li F; McMahon LA; Yang Q; Wang HL; Xu H
Biotech Histochem; 2012 Jan; 87(1):30-4. PubMed ID: 21838611
[TBL] [Abstract][Full Text] [Related]
29. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
30. Merkel cell carcinoma with an unusual immunohistochemical profile.
Pilloni L; Manieli C; Senes G; Ribuffo D; Faa G
Eur J Histochem; 2009 Dec; 53(4):e33. PubMed ID: 22073365
[TBL] [Abstract][Full Text] [Related]
31. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.
Nonaka D; Chiriboga L; Soslow RA
Am J Surg Pathol; 2008 Oct; 32(10):1566-71. PubMed ID: 18724243
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of putative renal cell carcinoma markers PAX-2, PAX-8, and hKIM-1 in germ cell tumors: a tissue microarray study of 100 cases.
Sangoi AR; McKenney JK; Brooks JD; Bonventre JV; Higgins JP
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):451-3. PubMed ID: 22495365
[TBL] [Abstract][Full Text] [Related]
33. PAX immunoreactivity identifies alveolar rhabdomyosarcoma.
Sullivan LM; Atkins KA; LeGallo RD
Am J Surg Pathol; 2009 May; 33(5):775-80. PubMed ID: 19145202
[TBL] [Abstract][Full Text] [Related]
34. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.
Long KB; Srivastava A; Hirsch MS; Hornick JL
Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099
[TBL] [Abstract][Full Text] [Related]
35. Utility of PAX8 mouse monoclonal antibody in the diagnosis of thyroid, thymic, pleural and lung tumours: a comparison with polyclonal PAX8 antibody.
Toriyama A; Mori T; Sekine S; Yoshida A; Hino O; Tsuta K
Histopathology; 2014 Oct; 65(4):465-72. PubMed ID: 24592933
[TBL] [Abstract][Full Text] [Related]
36. Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load.
Leroux-Kozal V; Lévêque N; Brodard V; Lesage C; Dudez O; Makeieff M; Kanagaratnam L; Diebold MD
Hum Pathol; 2015 Mar; 46(3):443-53. PubMed ID: 25623078
[TBL] [Abstract][Full Text] [Related]
37. PAX-8 expression in renal tumours and distant sites: a useful marker of primary and metastatic renal cell carcinoma?
Barr ML; Jilaveanu LB; Camp RL; Adeniran AJ; Kluger HM; Shuch B
J Clin Pathol; 2015 Jan; 68(1):12-7. PubMed ID: 25315900
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases.
Sangoi AR; Fujiwara M; West RB; Montgomery KD; Bonventre JV; Higgins JP; Rouse RV; Gokden N; McKenney JK
Am J Surg Pathol; 2011 May; 35(5):678-86. PubMed ID: 21490444
[TBL] [Abstract][Full Text] [Related]
39. Reactivity with TdT in Merkel cell carcinoma: a potential diagnostic pitfall.
Buresh CJ; Oliai BR; Miller RT
Am J Clin Pathol; 2008 Jun; 129(6):894-8. PubMed ID: 18480005
[TBL] [Abstract][Full Text] [Related]
40. The Toker tumor: spectrum of morphologic features in primary neuroendocrine carcinomas of the skin (Merkel cell carcinoma).
Plaza JA; Suster S
Ann Diagn Pathol; 2006 Dec; 10(6):376-85. PubMed ID: 17126260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]